| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Horizon Therapeutics Public Ltd Co | Chief Accounting Officer | Ordinary Shares | 0 | $116.50 | 06 Oct 2023 | Direct | |
| Horizon Therapeutics Public Ltd Co | Chief Accounting Officer | Restricted Stock Units | 0 | 06 Oct 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919123052366-mcilvenny-patrick-2023-10-06 | Horizon Therapeutics Public Ltd Co | 06 Oct 2023 | 4 | -$800,821 | 4 | Chief Accounting Officer | 06 Oct 2023, 18:08 |
| /report/000120919123002440-mcilvenny-patrick-2023-01-04 | Horizon Therapeutics Public Ltd Co | 04 Jan 2023 | 6 | -$469,606 | 4 | Chief Accounting Officer | 06 Jan 2023, 16:56 |
| /report/000120919122056577-mcilvenny-patrick-2022-11-11 | Horizon Therapeutics Public Ltd Co | 11 Nov 2022 | 0 | $0 | 3 | Chief Accounting Officer | 14 Nov 2022, 15:13 |